共 9 条
[6]
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1998, 16 (08)
:2659-2671
[8]
Simon R, 2001, CANCER RES, V61, P4514